{"id":"https://openalex.org/W4200425355","doi":"https://doi.org/10.26355/eurrev_202112_27448","title":"Rationale behind using valproic acid for Non-Hodgkin lymphoma: a biomolecular perspective.","display_name":"Rationale behind using valproic acid for Non-Hodgkin lymphoma: a biomolecular perspective.","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200425355","doi":"https://doi.org/10.26355/eurrev_202112_27448","pmid":"https://pubmed.ncbi.nlm.nih.gov/34919251"},"language":"en","primary_location":{"id":"pmid:34919251","doi":"https://doi.org/10.26355/eurrev_202112_27448","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34919251","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W4200425355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000949361","display_name":"Hastono Ridwansyah","orcid":"https://orcid.org/0000-0003-2737-6203","observed_orcids":["https://orcid.org/0000-0003-2737-6203"]},"institutions":[{"id":"https://openalex.org/I91819753","display_name":"Padjadjaran University","ror":"https://ror.org/00xqf8t64","country_code":"ID","type":"education","lineage":["https://openalex.org/I91819753"]}],"countries":["ID"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Ridwansyah","raw_affiliation_strings":["Graduate School of Biomedical Science, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia. ridwansyah19001@mail.unpad.ac.id"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Science, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia. ridwansyah19001@mail.unpad.ac.id","institution_ids":["https://openalex.org/I91819753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007524673","display_name":"Indra Wijaya","orcid":"https://orcid.org/0000-0002-9446-2307","observed_orcids":["https://orcid.org/0000-0002-9446-2307"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I Wijaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063715020","display_name":"Muhammad Hasan Bashari","orcid":"https://orcid.org/0000-0001-7298-0317","observed_orcids":["https://orcid.org/0000-0001-7298-0317"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M H Bashari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102919838","display_name":"Achmad Hussein Sundawa Kartamihardja","orcid":"https://orcid.org/0000-0003-2460-3386","observed_orcids":["https://orcid.org/0000-0003-2460-3386"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A H S Kartamihardja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110830232","display_name":"Bethy Surjawathy Hernowo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B S Hernowo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0621,"has_fulltext":false,"cited_by_count":2,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.20074532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"25","issue":"23","first_page":"7486","last_page":"7500"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.6815999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.6815999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.27639999985694885,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibition","display_name":"histone deacetylase inhibition","score":0.984000027179718},{"id":"https://openalex.org/keywords/epigenetic-modifications","display_name":"epigenetic modifications","score":0.9440000057220459},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.878000020980835},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8360000252723694},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6340000033378601},{"id":"https://openalex.org/keywords/bcl6","display_name":"BCL6","score":0.8109999895095825},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9750000238418579},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tumor-surveillance","display_name":"tumor surveillance","score":0.9190000295639038},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.6679999828338623},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.6671817302703857},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6571279168128967},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.5110763311386108},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.47754940390586853},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45159173011779785},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.4443759322166443},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4389982223510742},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.4187568128108978},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38689374923706055},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32795074582099915},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2647157311439514},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.2579340934753418},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2245471179485321},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2149553894996643},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.15700680017471313},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10225069522857666},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044127","descriptor_name":"Epigenesis, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:34919251","doi":"https://doi.org/10.26355/eurrev_202112_27448","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34919251","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2563955158","https://openalex.org/W2591468047","https://openalex.org/W2572038227","https://openalex.org/W2166158072","https://openalex.org/W2244368626","https://openalex.org/W2155696324","https://openalex.org/W2035557827","https://openalex.org/W266518141","https://openalex.org/W2078079917"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Non-Hodgkin":[1],"lymphoma":[2,185],"(NHL)":[3],"is":[4,18,87],"a":[5,9,35,88,232],"hematological":[6],"malignancy":[7],"with":[8,243],"high":[10],"rate":[11],"of":[12,48,70,81,148,150,159,166,172,183,188,194,206,213,217,226],"relapse":[13],"and":[14,104,130,192,198,215],"refractory":[15],"cases.":[16],"It":[17,133],"believed":[19],"to":[20,25,45,230,245],"be":[21,231],"caused":[22],"by":[23,51],"resistance":[24],"standard":[26,239],"treatment":[27,144,235,240],"modalities.":[28],"Valproic":[29],"acid":[30],"(VPA),":[31],"previously":[32],"used":[33],"as":[34,106,155,209],"broad-spectrum":[36],"anticonvulsant":[37],"drug,":[38],"has":[39],"been":[40],"proposed":[41],"for":[42,72,95,120,143],"NHL":[43,59,73,121,153,244],"owing":[44],"its":[46,78,223],"action":[47,149],"epigenetic":[49,129],"modification":[50],"inhibiting":[52],"histone":[53],"deacetylase.":[54],"However,":[55],"VPA":[56,71,123,151,228],"studies":[57],"on":[58,77,139,222],"are":[60,118,154],"limited.":[61],"This":[62,86],"review":[63],"describes":[64],"the":[65,68,107,140,157,164,210,238],"rationale":[66],"behind":[67],"use":[69],"treatment,":[74],"particularly":[75],"focusing":[76],"molecular":[79],"mechanism":[80,225],"action.":[82],"MATERIALS":[83],"AND":[84],"METHODS:":[85],"narrative":[89],"review.":[90],"The":[91,146],"literature":[92],"search":[93],"strategy":[94],"indexed":[96],"Scopus":[97],"articles":[98],"was":[99,113],"performed":[100],"randomly":[101],"using":[102],"PubMed":[103],"MEDLINE":[105],"primary":[108,211],"sources.":[109],"No":[110],"specific":[111],"term":[112],"used.":[114],"RESULTS:":[115],"Several":[116],"mechanisms":[117,127,147],"responsible":[119,142],"development.":[122],"can":[124],"modulate":[125],"these":[126],"via":[128,163],"nonepigenetic":[131],"modifications.":[132],"may":[134],"also":[135],"have":[136],"an":[137],"impact":[138],"proteins":[141],"resistance.":[145,247],"in":[152,241],"follows:":[156],"induction":[158,171],"cell":[160],"cycle":[161],"arrest":[162],"upregulation":[165,205],"cyclin-dependent":[167],"protein":[168],"kinase":[169],"inhibitors;":[170],"Apo2":[173],"ligand":[174],"or":[175],"tumor":[176,207,218],"necrosis":[177],"factor-related":[178],"apoptosis-inducing":[179],"ligand-induced":[180],"apoptosis;":[181],"inactivation":[182],"B-cell":[184],"6;":[186],"inhibition":[187],"Janus":[189],"kinase/signal":[190],"transducer":[191],"activator":[193],"transcription,":[195],"phosphoinositide":[196],"3-kinase/Akt,":[197],"nuclear":[199],"factor":[200],"kappa":[201],"B":[202],"signaling":[203],"pathways;":[204],"antigen":[208],"target":[212],"immunotherapy;":[214],"strengthening":[216],"immunosurveillance.":[219],"CONCLUSIONS:":[220],"Based":[221],"biomolecular":[224],"action,":[227],"appears":[229],"promising":[233],"initial":[234],"before":[236],"initiating":[237],"patients":[242],"overcome":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200425355","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2021-12-31T00:00:00"}
